User:ChrisMisu/Prescription drug prices in the United States/Bibliography

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.

Outline of proposed changes
Click on the edit button to draft your outline. This is a scientific journal provides insights into the interplay between sales volumes, drug innovation, and pricing dynamics. It suggests that allowing Medicare to negotiate could lead to lower drug prices for its beneficiaries. Pharmaceutical companies may face pressure to offer more competitive pricing to Medicare, given its large beneficiary base. The decision could impact the profit margins of pharmaceutical companies. However, there's an expectation that volume sales might offset some of the profit reductions.